Q-omics provides the consensus-scored NUP35P2 profile across patient tissues and cancer cell-line models. NUP35P2 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, NUP35P2 is differentially expressed in 2, with the highest sampling consensus in BRCA. Additionally, NUP35P2 RNA expression shows 6,075 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight READ, BRCA, and STAD as cancer lineages where NUP35P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for NUP35P2 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes NUP35P2 survival associations across molecular data types. NUP35P2 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible NUP35P2 RNA expression–survival associations across cancer types. High NUP35P2 expression shows unfavorable associations in READ, THCA, LUAD, OV, KIRC and STAD. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for NUP35P2 RNA expression.
This table summarizes NUP35P2 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for NUP35P2. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. NUP35P2 shows lower tumor expression in BRCA and LUSC. The BRCA box plot shows higher NUP35P2 RNA expression in normal versus tumor tissue (log2 FC = −0.007, t-test p = .009).
This table shows molecular features associated with NUP35P2 in patient tissues and cancer cell lines. In patient samples, NUP35P2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
